Home NDC 51655-132-52 NP Thyroid 60
Product NDC 51655-132
Requested package NDC 51655-132-52
11-digit product format 516550132
Labeler code 51655
Product ID 51655-132_499e0c2f-5884-47f3-e063-6394a90ad75e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name LEVOTHYROXINE, LIOTHYRONINE
Dosage form TABLET
Route ORAL
Labeler Northwind Health Company, LLC
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2015-02-12
Substance LEVOTHYROXINE; LIOTHYRONINE
Active strength 38; 9 ug/1; ug/1
Pharmacologic classes Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 10 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 9bebd1f3094a…5416666fcb17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base NP Thyroid 60
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LEVOTHYROXINE 38 ug/1 LIOTHYRONINE 9 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination Q51BO43MG4 Internal UNII lookup 06LU7C9H1V Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 313391 Internal RxNorm lookup 1724481 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51655-132-52 NP Thyroid 60 30 in 1 BOTTLE, DISPENSING TABLET 30 5
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51655-132 NP THYROID 60 (LEVOTHYROXINE, LIOTHYRONINE) TABLET [NORTHWIND PHARMACEUTICALS, LLC] 4 Current NDC, Legacy NDC, 1 package rows 20240726_ba633224-8f70-4533-a5fc-4dfd2df703d6.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 51655-132-52 51655013252 30 TABLET in 1 BOTTLE, DISPENSING (51655-132-52) 30 tablet 2015-02-12 No No Current